Program

Home

C. Hendrix: Prevention of HIV Transmission -PrEP


Dr. Craig Hendrix is an associate Professor of Medicine, Pharmacology, and Epidemiology at Johns Hopkins University where he is the Director of the Drug Development Unit which focuses on early phases of antiviral drug development. He has 19 years of post-fellowship experience as principal investigator of clinical research studies, primarily studying the pharmacokinetics and pharmacodynamics of new drugs for HIV infection.
Craig Hendrix received his undergraduate degree in Applied Biology at MIT and his medical degree from Georgetown University. He completed an Internship and Residency in Internal Medicine, and Fellowships in Infectious Diseases and Clinical Pharmacology at The Johns Hopkins Hospital.
Dr. Hendrix is an Associate Professor of Medicine, Pharmacology, and Epidemiology at Johns Hopkins University where he is the Director of the Drug Development Unit which focuses on early phases of antiviral drug development. He has 19 years of post-fellowship experience as principal investigator of clinical research studies, primarily studying the pharmacokinetics and pharmacodynamics of new drugs for HIV infection.  His primary research focus is chemoprevention of HIV infection which includes developing topical microbicides to prevent sexual transmission of HIV. He is the recipient of numerous teaching awards including the Johns Hopkins Alumni Association Excellence in Teaching Award and the David M. Levine Faculty Mentoring Award. Before joining the Hopkins medical school faculty, Dr. Hendrix served on active duty for 10 years in the U.S. Air Force where he was Director of the Air Force HIV Research Program and developed HIV prevention programs for the United States military, United Nations Department of Peacekeeping Operations, and other militaries worldwide.